Skip to main content
. Author manuscript; available in PMC: 2014 May 30.
Published in final edited form as: Clin Infect Dis. 2009 Jul 1;49(1):1–45. doi: 10.1086/599376

Table 6.

Antibiotic doses for pediatric patients.

Drug Intravenous dosing Maximum daily dosage Comments
Amikacin Neonates: 0–4 weeks of age and<1200 g, 7.5 mg/kg every 18–24 h; postnatal age ≤7 days and 1200–2000 g, 7.5 mg/kg every 12 h; postnatal age ≤7 days and >2000 g, 7.5–10 mg/kg every 12 h; postnatal age >7 days and 1200–2000 g, 7.5–10 mg/kg every 8–12 h; postnatal age >7 days and >2000 g, 10 mg/kg every 8 h
Infants and children: 15–22.5 mg/kg/day divided every 8 h
Some consultants recommend initial doses of 30 mg/kg/day divided every 8 h in patients whose serum levels document the need (i.e., cystic fibrosis or febrile neutropenic patients).
Ampicillin Neonates: postnatal age ≤7 days and ≤2000 g: 50 mg/kg/day divided every 12 h; postnatal age ≤7 days and >2000 g, 75 mg/kg/day divided every 8 h; postnatal age >7 days and <1200 g, 50 mg/kg/day divided every 12 h; postnatal age >7 days and 1200–2000 g, 75 mg/kg/day divided every 8 h; postnatal age >7 days and >2000 g, 100 mg/kg/day divided every 6 h
Infants and children: 100–200 mg/kg/day divided every 6 h
12 g
Ampicillin-sulbactam Infants: 100–150 mg ampicillin/kg/day divided every 6 h
Children: 100–200 mg ampicillin/kg/day divided every 6 h
8 g of ampicillin
Anidulafungin Children 2– 17 years of agea: 1.5 mg/kg/day 100 mg Experience in children is limited.
Caspofungin Children 2–11 years of age: loading dose of 70 mg/m2/day on day 1 followed by 50 mg/m2/day thereafter
Children ≥12 years of age: loading dose: 70 mg on day 1, followed by 50 mg once daily thereafter
70 mg (loading) 50 mg (maintenance)
Cefazolin Children >1 month of age: 75 mg/kg q8h
Cefepime Neonates ≤14 days of age: 30 mg/kg every 12 h
Infants > 14 days of ageb and Children ≤40 kg in weight: 50 mg/kg every 12 h
No recommendation available for infants 2 weeks to 2 months of age.
Ceftazidime Neonates: 0–4 weeks of age and <1200 g, 100 mg/kg/day divided every 12 h; postnatal age ≤7 days and 1200–2000 g, 100 mg/kg/day divided every 12 h; postnatal age ≤7 days and >2000 g: 100–150 mg/kg/day divided every 8–12 h; postnatal age >7 days and ≥1200 g, 150 mg/kg/day divided every 8 h
Infants and children ≤12 years of age: 100–150 mg/kg/day divided every 8 h
6 g
Cefotaxime Children >1 month of age 150 mg/kg every 8 h
Ceftriaxone Neonates: postnatal age ≤7 days, 50 mg/kg/day given every 24 h; postnatal age >7 days and ≤2000 g, 50 mg/kg/day given every 24 h; postnatal age >7 days and >2000 g, 50–75 mg/kg/day given every 24 h
Infants and children: 50–75 mg/kg/day divided every 12–24 h
Should not be used in hyperbilirubinemic neonates.
Ciprofloxacin Neonates: 7–40 mg/kg/day divided every 12 h
Infants and children: 20–30 mg/kg/day divided every 12 h
800 mg Experience in neonates is limited. The risks and benefits of fluoroquinolones in children should be assessed prior to use.
Fluconazole Neonates, infants, and children: 12 mg/kg/day once daily
Gentamicin Neonates: premature neonates and <1000 g, 3.5 mg/kg every 24 h; 0–4 weeks and <1200 g, 2.5 mg/kg every 18–24 h; postnatal age ≤7 days: 2.5 mg/kg every 12 h; postnatal age >7 days and 1200–2000 g, 2.5 mg/kg every 8–12 h; postnatal age >7 days and >2000 g, 2.5 mg/kg every 8 h; once daily dosing for premature neonates with normal renal function, 3.5–4 mg/kg every 24 h; once daily dosing for term neonates with normal renal function, 3.5–5 mg/kg every 24 h
Infants and children <5 years of age: 2.5 mg/kg every 8 h; once daily dosing in patients with normal renal function, 5–7.5 mg/kg every 24 h
Children ≥5 years of age: 2–2.5 mg/kg every 8 h; once daily dosing in patients with normal renal function, 5–7.5 mg/kg every 24 h
Some patients may require larger or more frequent doses (e.g., every 6 h) if serum levels document the need (i.e., cystic fibrosis, patients with major burns, or febrile neutropenic patients).
Imipenem-cilastatin Neonates: 0–4 weeks of age and <1200 g, 20 mg/kg every 18–24 h; postnatal age ≤7 days, and 1200–1500 g, 40 mg/kg/day divided every 12 h; postnatal age ≤7 days and >1500 g, 50 mg/kg/day divided every 12 h; postnatal age >7 days and 1200–1500 g, 40 mg/kg/day divided every 12 h; postnatal age >7 days and >1500 g, 75 mg/kg/day divided every 8 h
Infants <3 months of age: 100 mg/kg/day divided every 6 h
Infants ≥3 months of age and children: 60–100 mg/kg/day divided every 6 h
4 g
Levofloxacin Children 6 months to 5 years of age: 10 mg/kg every 12 h
Children ≥5 years of age: 10 mg/kg every 24 h with a maximum dose of 500 mg
500 mg Experience in children is limited. The risks and benefits of fluoroquinolones in children should be assessed prior to use.
Linezolid Neonates: 0–4 weeks of age and birthweight <1200 g: 10 mg/kg every 8–12 h (note: use every 12 h in patients <34 weeks gestation and <1 week of age); <7 days of age and birthweight ≥1200 g, 10 mg/kg every 8–12 h (note: use every 12 h in patients < 34 weeks gestation and < 1 week of age); ≥7 days and birthweight ≥1200 g, 10 mg/kg every 8 h
Infants and children <12 years of age: 10 mg/kg every 8 h
Children ≥12 years of age and adolescents: 10 mg/kg every 12 h
600 mg
Meropenem Neonates: postnatal age 0–7 days, 20 mg/kg every 12 h; postnatal age >7 days and 1200–2000 g, 20 mg/kg every 12 h; postnatal age >7 days and >2000 g, 20 mg/kg every 8 h
Infants ≥3 months of age and children: 20 mg/kg every 8 h
1 g
Micafungin Children >2 years of age: 3 mg/kg/day 150 mg Younger children, infants, and neonates are likely to require higher doses, but no recommendation is currently available.
Nafcillin Neonates: 0–4 weeks of age and <1200 g, 50 mg/kg/day in divided doses every 12 h; ≤7 days and 1200–2000 g, 50 mg/kg/day in divided doses every 12 h; ≤7 days of age and >2000 g, 75 mg/kg/day in divided doses every 8 h; >7 days of age and 1200–2000 g, 75 mg/kg/day in divided doses every 8 h; >7 days of age and >2000 g, 100 mg/kg/day in divided doses every 6 h
Infants and children: 100–200 mg/kg/day in divided doses every 4–6 h
12 g
Oxacillin Neonates: 0–4 weeks of age and <1200 g, 50 mg/kg/day in divided doses every 12 h; postnatal age <7 days and 1200–2000 g: 50–100 mg/kg/day in divided doses every 12 h; postnatal age <7 days and 1200–2000 g, 75–150 mg/kg/day in divided doses every 8 h; postnatal age ≥7 days and 1200–2000 g: 75–150 mg/kg/day in divided doses every 8 h; postnatal age ≥7 days and >2000 g, 75–150 mg/kg/day in divided doses every 8 h
Infants and children: 150–200 mg/kg/day in divided doses every 4–6 h
12 g
Quinupristin-dalfopristin Infants and children: 7.5 mg/kg every 8 h Experience in children is limited. Recommended dosage based on 0.1 to 18 years of age.
Ticarcillin Neonates: postnatal age ≤7 days and ≤2000 g, 150 mg/kg/day in divided doses every 12 h; postnatal age ≤7 days and >2000 g, 225 mg/kg/day in divided doses every 8 h; postnatal age >7 days and <1200 g, 150 mg/kg/day in divided doses every 12 h; postnatal age >7 days and 1200–2000 g, 225 mg/kg/day in divided doses every 8 h; postnatal age >7 days and >2000 g, 300 mg/kg/day in divided doses every 6–8 h
Infants and children: 200–300 mg/kg/day in divided doses every 4–6
24 g
Tobramycin Neonates: preterm neonates <1000 g, 3.5 mg/kg every 24 h; 0–4 weeks of age and <1200 g, 2.5 mg/kg every 18 h; postnatal age ≤7 days and 1200–2000 g, 2.5 mg/kg every 12 h; postnatal age ≤7 days and >2000 g, 2.5 mg/kg every 8 h
Infants and children <5 years of age: 2.5 mg/kg every 8 h
Children ≥5 years of age: 2–2.5 mg/kg every 8 h
Some patients may require larger or more frequent doses (e.g., every 6 h) if serum levels document the need (i.e., cystic fibrosis, patients with major burns, or febrile neutropenic patients).
TMP-SMX Infants >2 months of age and children: mild-to-moderate infections, 6–12 mg TMP/kg/day in divided doses every 12 h; serious infection, 15–20 mg TMP/kg/day in divided doses every 6–8 h
Vancomycin Neonates: postnatal age ≤7 days and <1200 g, 15 mg/kg/day given every 24 h; postnatal age ≤7 days and 1200–2000 g, 10–15 mg/kg given every 12–18 h; postnatal age ≤7 days and >2000 g, 10–15 mg/kg given every 8–12 h; postnatal age >7 days and <1200 g, 15 mg/kg/day given every 24 h; postnatal age >7 days and 1200–2000 g, 10–15 mg/kg given every 8–12 h; postnatal age >7 days and >2000 g, 15–20 mg/kg given every 8 h
Infants and children: 40 mg/kg/day in divided doses every 6–8 h
Voriconazole Children >2 years of age: 7 mg/kg every 12 h for 2 doses on day 1 (loading dose) followed by 4 mg/kg every 12 h (note: doses as high as 8 mg/kg every 12 h have been reported

NOTE. Intravenous dosing is given according to Pediatric Lexi-Comp Drugs Web site [279], unless otherwise indicated. Neonates are <4 weeks of age and infants are 4 weeks to 1 year of age, unless otherwise specified. TMP-SMZ, trimethoprim-sulfamethoxazole.

a

Benjamin et al. [280].

b

Neofax 2008.